• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多学科心脏团队指导下的复杂冠状动脉疾病管理后的长期生存情况。

Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.

作者信息

Pickering Taylor, Kluis Austin, Shih Emily, Squiers John J, McCullough Kyle, Dorton Cody, Moore David O, Potluri Srinivasa P, Szerlip Molly, Al-Azizi Karim, Moubarak Ghadi, Ladner Jonathan, Vaishnav Radhika, McCoy Shelby, Ejiofor Julius, Sawhney Rahul, Hale Sarah, Schaffer Justin M, Banwait Jasjit, Harrington Katherine B, Brinkman William T, Hafen Lee R, Smith Robert L, George Timothy J, DiMaio J Michael, Ryan William H, Hutcheson Kelley A

机构信息

Baylor Scott & White Research Institute, Plano, Texas, USA.

Department of Cardiothoracic Surgery, Baylor Scott & White The Heart Hospital - Plano, Plano, Texas, USA.

出版信息

Proc (Bayl Univ Med Cent). 2025 Jun 20;38(5):589-597. doi: 10.1080/08998280.2025.2516981. eCollection 2025.

DOI:10.1080/08998280.2025.2516981
PMID:40821489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12351742/
Abstract

OBJECTIVE

Guidelines recommend a multidisciplinary heart team approach for managing complex coronary artery disease (CAD), yet its impact on clinical outcomes and adherence to recommendations is rarely reported.

METHODS

Between June 2021 and August 2022, 210 high-risk patients with isolated, complex CAD were evaluated at our institution's weekly heart team conference for consideration of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), hybrid PCI/CABG, or optimal medical therapy (OMT). Adherence to recommendations and clinical outcomes, including 30-day, 1-year, and 2-year mortality, were assessed.

RESULTS

Overall adherence to heart team recommendations was 92%, with 96% adherence for CABG, 90% for PCI, 87% for OMT, and 75% for hybrid PCI/CABG. CABG was the most frequently recommended treatment (53%) and demonstrated the lowest mortality at 1 year (4%) and 2 years (6%) compared with PCI (1 year, 28%; 2 year, 40%) and OMT (1 year, 10%; 2 year, 20%). CABG patients had a lower-than-expected mortality (observed-to-expected ratio 0.9), while PCI was associated with significantly higher mortality (observed-to-expected ratio 3.0).

CONCLUSION

This single-center multidisciplinary heart team approach for complex CAD offers a collaborative, patient-centered model that facilitates high adherence rates and favorable patient outcomes. These findings highlight the potential benefits of integrating multidisciplinary evaluation and support its implementation into standard practice for high-risk CAD patients.

摘要

目的

指南推荐采用多学科心脏团队方法来管理复杂冠状动脉疾病(CAD),但其对临床结局和推荐意见依从性的影响鲜有报道。

方法

在2021年6月至2022年8月期间,在我们机构每周的心脏团队会议上对210例孤立性、复杂性CAD高危患者进行评估,以考虑冠状动脉旁路移植术(CABG)、经皮冠状动脉介入治疗(PCI)、杂交PCI/CABG或最佳药物治疗(OMT)。评估对推荐意见的依从性和临床结局,包括30天、1年和2年死亡率。

结果

对心脏团队推荐意见的总体依从率为92%,CABG的依从率为96%,PCI为90%,OMT为87%,杂交PCI/CABG为75%。CABG是最常被推荐的治疗方法(53%),与PCI(1年,28%;2年,40%)和OMT(1年,10%;2年,20%)相比,其1年(4%)和2年(6%)死亡率最低。CABG患者的死亡率低于预期(观察到的与预期的比率为0.9),而PCI则与显著更高的死亡率相关(观察到的与预期的比率为3.0)。

结论

这种针对复杂CAD的单中心多学科心脏团队方法提供了一种协作性、以患者为中心的模式,有助于提高依从率并使患者获得良好结局。这些发现凸显了整合多学科评估的潜在益处,并支持将其纳入高危CAD患者的标准治疗实践中。

相似文献

1
Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.多学科心脏团队指导下的复杂冠状动脉疾病管理后的长期生存情况。
Proc (Bayl Univ Med Cent). 2025 Jun 20;38(5):589-597. doi: 10.1080/08998280.2025.2516981. eCollection 2025.
2
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较:一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
3
Comparing AI-Driven and Heart Team Decision-Making in Multivessel Coronary Artery Disease.多支冠状动脉疾病中人工智能驱动决策与心脏团队决策的比较
J Clin Med. 2025 Jun 23;14(13):4452. doi: 10.3390/jcm14134452.
4
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
5
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄患者:系统评价与荟萃分析
Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
8
Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.多支血管病变或左主干冠状动脉疾病行经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗 10 年的结局:系统评价和荟萃分析。
J Cardiothorac Surg. 2023 Feb 2;18(1):54. doi: 10.1186/s13019-023-02101-y.
9
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.系统评价:经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较疗效
Ann Intern Med. 2007 Nov 20;147(10):703-16. doi: 10.7326/0003-4819-147-10-200711200-00185. Epub 2007 Oct 15.
10
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.左主干冠状动脉狭窄:药物洗脱支架与冠状动脉旁路移植术的荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1219-30. doi: 10.1016/j.jcin.2013.07.008.

本文引用的文献

1
Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.设立用于高危冠状动脉血运重建的正式多学科心脏团队。
Proc (Bayl Univ Med Cent). 2024 Nov 22;38(1):28-33. doi: 10.1080/08998280.2024.2426925. eCollection 2025.
2
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges.心血管医学中的多学科心脏团队:当前作用与未来挑战
JACC Adv. 2023 Jan 11;2(1):100160. doi: 10.1016/j.jacadv.2022.100160. eCollection 2023 Jan.
3
Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial.左主干病变 PCI 后不完全血运重建的影响:EXCEL 试验。
Circ Cardiovasc Interv. 2024 Mar;17(3):e013192. doi: 10.1161/CIRCINTERVENTIONS.123.013192. Epub 2024 Mar 19.
4
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease.比较左主干或多支血管病变的 80 岁以上高龄患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗的结局。
Sci Rep. 2023 Dec 15;13(1):22323. doi: 10.1038/s41598-023-49069-2.
5
The experiences of patients with advanced heart failure, family carers, and health professionals with palliative care services: a secondary reflexive thematic analysis of longitudinal interview data.晚期心力衰竭患者、家庭护理者以及姑息治疗服务的卫生专业人员的体验:纵向访谈数据的二次反思性主题分析。
BMC Palliat Care. 2023 Aug 10;22(1):115. doi: 10.1186/s12904-023-01241-1.
6
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence.推进血液学中的姑息治疗整合:基于现有证据。
Curr Treat Options Oncol. 2023 May;24(5):542-564. doi: 10.1007/s11864-023-01084-1. Epub 2023 Apr 5.
7
Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.多支血管病变或左主干冠状动脉疾病行经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗 10 年的结局:系统评价和荟萃分析。
J Cardiothorac Surg. 2023 Feb 2;18(1):54. doi: 10.1186/s13019-023-02101-y.
8
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
9
Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.预测行经皮冠状动脉介入治疗患者的院内死亡率。
J Am Coll Cardiol. 2021 Jul 20;78(3):216-229. doi: 10.1016/j.jacc.2021.04.067. Epub 2021 May 3.
10
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease.多支冠状动脉疾病患者治疗中心脏团队与介入心脏病专家推荐的比较。
JAMA Netw Open. 2020 Aug 3;3(8):e2012749. doi: 10.1001/jamanetworkopen.2020.12749.